Articles
Guest Editorial
Registration of clinical trials benefits everyone
Intravitreal Injection Survey
Part 2 - Dealing with complications.
Special Report: Cost and Reimbursement Survey
Will you be replacing Avastin with Lucentis?
Statement on Avastin
Position statement released by AMD Alliance International.
State-of-the-Art Imaging Technology
A review of new advances in diagnostic retinal imaging.
Subspecialty News
Lucentis gets FDA OK, and more
Telescopic Technology
IMT trials show siginificant visual acuity and quality-of-life gains for AMD patients.
Upfront
From the editor-in-chief
Advertisement
Recommendations
Advertisement
Advertisement